184 related articles for article (PubMed ID: 38674854)
1.
Liu D; Li C; Cao T; Lv X; Yue Y; Li S; Cheng Y; Liu F; Huo G; Li B
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674854
[TBL] [Abstract][Full Text] [Related]
2. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
[TBL] [Abstract][Full Text] [Related]
3. Human cathelicidin LL-37 exerts amelioration effects against EHEC O157:H7 infection regarding inflammation, enteric dysbacteriosis, and impairment of gut barrier function.
Fang X; Nong K; Wang Z; Jin Y; Gao F; Zeng Q; Wang X; Zhang H
Peptides; 2023 Jan; 159():170903. PubMed ID: 36370932
[TBL] [Abstract][Full Text] [Related]
4. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches.
Thévenot J; Cordonnier C; Rougeron A; Le Goff O; Nguyen HT; Denis S; Alric M; Livrelli V; Blanquet-Diot S
Appl Microbiol Biotechnol; 2015 Nov; 99(21):9097-110. PubMed ID: 26084888
[TBL] [Abstract][Full Text] [Related]
5. Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7 challenged mice by improving epithelial function and balancing the microbiota in the intestine.
Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Beibei W; Jifeng Z; Xuemei W; Kebang W
Sci Rep; 2019 Jul; 9(1):9456. PubMed ID: 31263234
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory activity of Bifidobacterium longum HY8001 against Vero cytotoxin of Escherichia coli O157:H7.
Kim SH; Yang SJ; Koo HC; Bae WK; Kim JY; Park JH; Baek YJ; Park YH
J Food Prot; 2001 Nov; 64(11):1667-73. PubMed ID: 11726142
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains.
Yoshimura K; Matsui T; Itoh K
Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297
[TBL] [Abstract][Full Text] [Related]
8. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice.
Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H
Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157
[TBL] [Abstract][Full Text] [Related]
10. Early immune innate hallmarks and microbiome changes across the gut during Escherichia coli O157: H7 infection in cattle.
Larzábal M; Da Silva WM; Multani A; Vagnoni LE; Moore DP; Marin MS; Riviere NA; Delgado FO; Vilte DA; Victorica MR; Ma T; Le Guan L; Talia P; Cataldi A; Cobo ER
Sci Rep; 2020 Dec; 10(1):21535. PubMed ID: 33299023
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Clostridium species lower host susceptibility to enterohemorrhagic Escherichia coli O157:H7 infection.
Koyanagi Y; Suzuki R; Ihara K; Miyagi H; Isogai H; Yoneyama H; Isogai E
Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31344225
[TBL] [Abstract][Full Text] [Related]
12. Oral Administration of Bovine Lactoferrin-Derived Lactoferricin (Lfcin) B Could Attenuate Enterohemorrhagic Escherichia coli O157:H7 Induced Intestinal Disease through Improving Intestinal Barrier Function and Microbiota.
Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Jifeng Z; Xuemei W; Beibei W
J Agric Food Chem; 2019 Apr; 67(14):3932-3945. PubMed ID: 30892034
[TBL] [Abstract][Full Text] [Related]
13. Bifidobacterium spp. influences the production of autoinducer-2 and biofilm formation by Escherichia coli O157:H7.
Kim Y; Lee JW; Kang SG; Oh S; Griffiths MW
Anaerobe; 2012 Oct; 18(5):539-45. PubMed ID: 23010308
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
15. Magnesium Sensing Regulates Intestinal Colonization of Enterohemorrhagic Escherichia coli O157:H7.
Liu Y; Han R; Wang J; Yang P; Wang F; Yang B
mBio; 2020 Nov; 11(6):. PubMed ID: 33173003
[TBL] [Abstract][Full Text] [Related]
16. Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection.
Yi H; Hu W; Chen S; Lu Z; Wang Y
J Immunol; 2017 Feb; 198(4):1696-1705. PubMed ID: 28062699
[TBL] [Abstract][Full Text] [Related]
17. Lcn2 deficiency accelerates the infection of Escherichia coli O157:H7 by disrupting the intestinal barrier function.
Zhang K; Chen J; Liang L; Wang Z; Xiong Q; Yu H; Du H
Microb Pathog; 2023 Dec; 185():106435. PubMed ID: 37931825
[TBL] [Abstract][Full Text] [Related]
18.
Liu B; Liu Y; Yang B; Wang Q; Liu X; Qin J; Zhao K; Li F; Feng X; Li L; Wu P; Liu M; Zhu S; Feng L; Wang L
Proc Natl Acad Sci U S A; 2022 Nov; 119(48):e2212436119. PubMed ID: 36409903
[TBL] [Abstract][Full Text] [Related]
19. Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.
Sanchez-Villamil JI; Tapia D; Torres AG
mBio; 2019 Aug; 10(4):. PubMed ID: 31409688
[TBL] [Abstract][Full Text] [Related]
20. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice.
Gagnon M; Kheadr EE; Dabour N; Richard D; Fliss I
Int J Food Microbiol; 2006 Aug; 111(1):26-33. PubMed ID: 16822570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
